![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 34, 30832-30837, August 23, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, May 16, 2002
Cockayne syndrome (CS) is a human disease
characterized by sensitivity to sunlight, severe neurological
abnormalities, and accelerated aging. CS has two complementation
groups, CS-A and CS-B. The CSB gene encodes the CSB protein
with 1493 amino acids. We previously reported that the CSB protein is
involved in cellular repair of 8-hydroxyguanine, an abundant lesion in
oxidatively damaged DNA and that the putative helicase motif V/VI of
the CSB may play a role in this process. The present study investigated the role of the CSB protein in cellular repair of 8-hydroxyadenine (8-OH-Ade), another abundant lesion in oxidatively damaged DNA. Extracts of CS-B-null cells and mutant cells with site-directed mutation in the motif VI of the putative helicase domain incised 8-hydroxyadenine in vitro less efficiently than wild type
cells. Furthermore, CS-B-null and motif VI mutant cells accumulated
more 8-hydroxyadenine in their genomic DNA than wild type cells after exposure to Cockayne syndrome (CS)1
is a human genetic disorder with diverse clinical symptoms (1). There
are two complementation groups of CS, CS-A and CS-B. The CSB
gene (CSB) encodes the CSB protein (CSB) with 1493 amino
acids and a molecular mass of 168 kDa (2, 3). An important clinical
feature of CS-B is accelerated aging. Thus, CS-B may be a useful model
for studying the aging process in humans. Fibroblasts from CS-B
patients are hypersensitive to ultraviolet (UV) radiation and show
delayed recovery of RNA synthesis after exposure (1). CS-B cells have a
pronounced defect in repair of UV radiation-induced DNA damage in
actively transcribed genes (4). UV radiation-induced DNA damages are
mostly bulky helix-distorting lesions that are removed by
nucleotide-excision repair (NER). The transcription-coupled repair
(TCR) pathway specifically removes these lesions in actively
transcribed genes (5). CS-B cells are deficient in TCR, and this is
thought to be the molecular basis of some features of the CS phenotype
(6), especially the increased sensitivity to UV radiation. However, it
is unlikely that the TCR defect and the resulting UV radiation
sensitivity of CS-B cells account for other clinical features of CS
such as progressive neurodegeneration. Thus, CS-B cells may be
deficient in other processes besides TCR of UV radiation-induced DNA damage.
All organisms are continuously exposed to reactive oxygen species,
which cause cellular damage and are thought to contribute to the aging
process (7). Reactive oxygen species damage DNA and generate numerous
DNA lesions such as modified bases and sugar moieties, strand breaks,
and DNA-protein cross-links (reviewed in Ref. 8).
8-hydroxy-7,8-dihydroguanine (8-OH-Gua) is a ubiquitous lesion in
oxidatively damaged DNA that is mutagenic, causing G Studies suggest that oxidative damage to DNA may contribute to the
premature aging phenotype associated with progeroid syndromes (20).
Thus, it is possible that the DNA repair defect in CS plays an
important role in the course and symptoms of this disorder. Whole cell
extracts (WCEs) from primary CS-B cells incise 8-OH-Gua at a lower rate
than normal cell lines, and this deficiency is complemented by
transfection of the cells with wild type CSB (21). In
addition, CS-B-null cells and CS-B motif V/VI mutants are more sensitive to In this study, we investigated the role of CSB
in cellular repair of 8-OH-Ade. CSB mutants were expressed
in CS-B-null cells and in vitro incision of 8-OH-Ade was
analyzed using WCEs from these cell lines. In addition, the nucleoside
form of 8-OH-Ade, 8-hydroxy-2'-deoxyadenosine (8-OH-dAdo) was measured
in genomic DNA of these cells by means of a recently developed assay
that uses liquid chromatography/mass spectrometry (LC/MS) with the isotope dilution technique (17).
Cell Lines and Culture Conditions--
Cell lines were derived
from CS1AN.S3.G2, a SV40-transformed human fibroblast in which
CSB is disrupted. These cells were described previously
(23). CS1AN.S3.G2 was transfected with pcDNA3.1 carrying the wild
type CSB, mutant CSB altered in the putative
helicase motif VI (Q942E and R946A) or the vector pcDNA3.1 (pc3.1)
(Invitrogen) (Fig. 2). The reason we
applied Q942E and R946A is that these cell lines are the most deficient
ones in repair of 8-OH-Gua among the 8 stably transfected cell lines
established in this laboratory with site-directed mutation(s), which
are distributed in various motifs of the helicase domain (22).
Construction of the mutants and cell lines were described previously
(22, 24).
Exposure was carried out as follows. Cells attached on
10-cm2 dishes were washed with phosphate-buffered saline
and then irradiated at the indicated doses with Gammacell 40 Exactor
137Cs In Vitro Incision of an 8-OH-Ade-containing
Oligonucleotide--
An oligonucleotide with a single 8-OH-Ade at
position 11 was the substrate for the incision assay. The sequences of
the oligonucleotide used in the incision assay are listed in Table
I. The oligonucleotide with the lesion
was 32P-5'-end-labeled and annealed with a complementary
strand containing a T opposite 8-OH-Ade. We also used a double-stranded
substrate containing C opposite the lesion because this structure is
the optimal substrate for nick-forming activity at position of 8-OH-Ade (25, 26). Incision reactions were carried out in a volume of 20 µl
containing 100 fmol of oligonucleotide duplex, 1 µg of poly(dIdC)
competitor, 20 mM Hepes-KOH, pH 7.8, 100 mM
KCl, 5 mM dithiothreitol, 5 mM EDTA, 2 mM MgCl2, and 40 µg of WCE protein prepared
as described (22, 27). Reactions were incubated at 37 °C for 3 h, terminated by the addition of 0.8 µl of 10% SDS and 0.8 µl of 5 mg/ml proteinase K, and incubated for 10 min at 55 °C. DNA was
precipitated with 2 µl of 5 mg/ml glycogen (Ambion), 4 µl of 11 M ammonium acetate, and 70 µl of cold ethanol overnight at LC/MS and Preparation of the Stable Isotope-labeled
Analog of 8-OH-dAdo--
The measurement of 8-OH-dAdo in enzymic
hydrolysates of DNA samples was performed by liquid
chromatography/isotope-dilution mass spectrometry (LC/IDMS) as
previously described except for the stable isotope-labeled internal
standard, which was used for quantification by IDMS (17). In the
present work, a stable isotope-labeled analog of 8-OH-dAdo was prepared
and isolated in pure form. Commercially available
[15N5]dATP (Medical Isotopes, Inc. Pelham,
NH) was used as the starting material. An aqueous solution of
[15N5]dATP (5 mg/100 ml) was bubbled
with N2O and exposed to ionizing radiation in a
60Co
Analytical LC/MS was carried out to confirm the identity of
8-OH-[15N5]dAdo and its purity. The isolated
compound was pure and did not contain any detectable unlabeled
8-OH-dAdo. The elution time of
8-OH-[15N5]dAdo was the same as that of
8-OH-dAdo, and its mass spectrum was similar to that of 8-OH-dAdo (17).
As expected, however, the masses of the typical ions of
8-OH-[15N5]dAdo were shifted by 5 Da to
greater masses, i.e. m/z 157 (the protonated base ion (BH
8-OH-dAdo was measured in DNA samples spiked with 2 pmol of
8-OH-[15N5]dAdo per 70 µg of DNA. The
concentration of DNA samples was determined by UV spectrophotometry.
DNA samples were hydrolyzed with nuclease P1, phosphodiesterase I, and
alkaline phosphatase as described (17) and filtered by centrifugation
at 6000 × g for 30 min using an ultrafiltration
membrane with a molecular mass cutoff of 5 kDa. An aliquot of 20 µl
of the filtered samples containing 20 µg of hydrolyzed DNA was
injected on the LC column. Characteristic ions of 8-OH-dAdo at
m/z 152 (BH Statistics--
Groups were compared using one-way analysis of
variance tests. Duncan's multiple range test was used for post-hoc
comparison of means. Differences were considered significant when
p < 0.05.
In this study, we investigated the possibility that CSB is
involved in cellular repair of 8-OH-Ade, a major lesion in oxidatively damaged DNA. 8-OH-Ade repair was assessed and compared in wild type,
CS-B-null, and putative CS-B helicase motif VI mutant cells. Glycosylase/apurinic lyase activity in CS-B cell lines was quantified by measuring incision of an oligonucleotide with a single 8-OH-Ade residue. Fig. 3A shows the
incision activity of wild type, CS-B-null, and two CS-B mutant cell
lines, and the results are summarized in Fig. 3B. Fig.
4, A and B show
similar results, the only difference being that we used the substrate
with C opposite the 8-OH-Ade lesion to possibly generate maximal
nick-forming activity (25, 26). CS-B-null and mutant cell lines incise
8-OH-Ade less efficiently than wild type cells in both situations. The
activity of CS-B-null cells was ~3-fold lower than wild type cells
(p < 0.05), and the activity of motif VI mutants
(CSBQ942E and CSBR946A) was ~2-fold lower than wild type cells
(p < 0.05). There were no differences in uracil or
5-hydroxycytocine incision of WCE of the tested cell lines (data not
shown) (22).
The Cockayne Syndrome Group B Gene Product Is Involved in
Cellular Repair of 8-Hydroxyadenine in DNA*
,
¶
Laboratory of Molecular Gerontology, NIA,
National Institutes of Health, Baltimore, Maryland 21224 and the
§ Chemical Science and Technology Laboratory, National
Institute of Standards and Technology, Gaithersburg, Maryland
20899-8311
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-radiation at doses of 2 or 5 Gy. These results
suggest that the CSB protein contributes to cellular repair of 8-OH-Ade and that the motif VI of the putative helicase domain of CSB is required for this activity.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
T
transversions in vitro and in vivo (9, 10).
8-hydroxy-7,8-dihydroadenine (8-OH-Ade) is another common lesion formed
in DNA exposed to oxidizing agents such as hydroxyl radicals in
vitro and in vivo (reviewed in Ref. 8 and structure is
shown in Fig. 1). 8-OH-Ade is
premutagenic and induces A
G and A
C mutations in mammalian
cells, although it leads to a lower mutation frequency than 8-OH-Gua
(11-16). Nevertheless, the biological consequences of 8-OH-Ade could
be significant, because it is abundant in oxidatively damaged DNA (17).
8-OH-Ade is repaired in mammalian cells (18), but the mechanism by
which it is repaired is not known (19).

View larger version (11K):
[in a new window]
Fig. 1.
Structure of
8-hydroxyadenine.
-radiation than wild type cells (22). WCEs from transfected CS-B-null cells and motif V/VI mutants also incise 8-OH-Gua-containing oligonucleotides less efficiently than wild type
cells. Furthermore, 8-OH-Gua accumulates to a greater level in
CS-B-null cells and motif VI mutants following
-irradiation than in
wild type cells (22).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (9K):
[in a new window]
Fig. 2.
Structure of CSB and the location of designed
mutants. The protein contains the seven conserved helicase motifs,
a highly acidic region, two nuclear localization signals
(NLS), and a nucleotide binding domain (NTB).
CSBQ942E is constructed by replacing a glutamine residue highly
conserved in the SNF2 family with a negatively charged glutamic acid.
CSBR946A is constructed by replacing an arginine residue highly
conserved in the SNF2 family with alanine.
-source (Nordian International Inc., Kanata,
Ontario, Canada) followed by incubation in the complete medium at
37 °C for 30 min. Genomic DNA was extracted as described (22).
20 °C. Samples were centrifuged for 1 h at 4 °C, washed
with 200 µl of 70% ethanol, and collected by centrifugation at
12,000 × g for 10 min. The pellet was dried in a
speed-vacuum and resuspended in 10 µl of formamide-loading dye (5%
EDTA, 0.02% bromphenol blue, 0.02% xylene cyanol in 95% formamide).
Samples were separated on a denaturing 20% polyacrylamide gel
(containing 7 M urea, 89 mM Tris borate, pH
8.0, and 2 mM EDTA). The reaction products were visualized
by autoradiography and quantified on a PhosphorImager (Molecular
Dynamics). Oligonucleotides containing a single uracil or
5-hydroxycytosine, which were known to have no differences in
incision activity of our CS-B wild type, null, or mutant cell lines,
were used as the WCE control (22).
The oligonucleotides used in incision assay
-source at a dose of 400 Gy (30 Gy/min). This
treatment was expected to produce
8-OH-[15N5]dATP from
[15N5]dATP among other products, because it
is well known that the exposure of aqueous solutions of dAdo to
ionizing radiation generates 8-OH-dAdo (reviewed in Refs. 28 and 29).
8-OH-[15N5]dATP was dephosphorylated to
8-OH-[15N5]dAdo as follows: an aliquot of 100 ml of the irradiated solution of [15N5]dATP
was lyophilized to dryness, dissolved in 1 ml of 10 mM phosphate buffer (pH 8.0), and incubated with alkaline phosphatase (5 units) at 37 °C for 24 h. The sample was filtered by
centrifugation at 6000 × g for 30 min through an
ultrafiltration membrane with a molecular mass cutoff of 5 kDa
(Millipore Corp., Bedford, MA). An aliquot (5 µl) of the filtered
sample was analyzed by LC/MS and found to contain
8-OH-[15N5]dAdo on the basis of the
previously reported LC/MS analysis of 8-OH-Ado (17). Semipreparative LC
was used to isolate 8-OH-[15N5]dAdo from an
irradiated and dephosphorylated sample of
[15N5]dATP using a Supelcosil LC-8 DB
reversed-phase column (25 × 1 cm inner diameter, 5-µm particle
size) (Supelco, Bellefonte, PA). The solvents and the elution gradient
were as previously described (17), except that a flow rate of 2 ml/min
was used. The column was kept at room temperature. Under the
experimental conditions used, 8-OH-[15N5]dAdo
eluting at 18.3 min was completely separated from
[15N5]dAdo, which eluted at 17.3 min. This is
the same elution order previously described for the unlabeled analogues
of these compounds using an analytical LC column (17). The fractions
corresponding to 8-OH-[15N5]dAdo were
collected. At least 30 injections of 100 µl were performed. Collected
fractions were combined, dried in a SpeedVac under vacuum, and then
dissolved in 200 µl of water. The absorption spectrum of the solution
was recorded between the wavelengths of 210 and 350 nm. The spectrum
was identical to the absorption spectrum of authentic 8-OH-dAdo
(30).

1 cm
1 at 270 nm (30) and by
LC/MS using a 0.1 mM solution of 8-OH-dAdo as an internal
standard. Both measurements yielded essentially identical results. The
concentration of the solution of
8-OH-[15N5]dAdo was 0.037 ± 0.003 mM.


![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (42K):
[in a new window]
Fig. 3.
Glycosylase/apurinic lyase activities on
8-OH-Ade in wild type and CSB mutant cells. The
substrate contained T paired with 8-OH-Ade. A, incubations
were carried out for 3 h, and reaction products were analyzed by
denaturing polyacrylamide gel electrophoresis. The substrate is a
28-mer, and the product is 11-mer. B, quantification of
8-OH-Ade glycosylase/apurinic lyase activity. The mean values (± S.D.)
from four independent experiments are shown. Asterisks
indicate values that are significantly different from CSBWT
(p < 0.05).

View larger version (46K):
[in a new window]
Fig. 4.
Structure of CSB and the location of designed
mutants, but the substrate used contains a C opposite the 8-OH-Ade
lesion.
The role of CSB in repairing 8-OH-Ade was also examined by measuring
the level of 8-OH-Ade in DNA of cells exposed to
-radiation at doses
of 2 or 5 Gy. 8-OH-Ade was measured as its nucleoside 8-OH-dAdo in wild
type, CS-B-null, motif VI mutant cells using LC/IDMS, a recently
developed assay for identification and quantification of oxidatively
modified DNA nucleosides (17). DNA samples isolated from cells were
hydrolyzed to nucleosides by endo- and exonucleases. Prior to
hydrolysis, an aliquot of 8-OH-[15N5]dAdo was
added as internal standard to the DNA samples. LC/IDMS was carried out
in SIM mode to monitor the characteristic ions of 8-OH-dAdo and
8-OH-[15N5]dAdo at the appropriate retention
time period, when these compounds eluted. The
BH


-radiation at 2 Gy. The results showed unequivocal identification of 8-OH-dAdo in DNA
from all cell lines used in this study. The quantification was achieved
by the integration of the signals of the monitored ions such as those
in Fig. 5 and the calculation of the level of 8-OH-dAdo on the basis of
the known amount of 8-OH-[15N5]dAdo added to
the DNA samples as an internal standard prior to enzymic
hydrolysis.
|
Fig. 6 shows the level of 8-OH-dAdo in
cells following exposure to ionizing radiation. Cells were irradiated
and allowed 30 min to recover and repair radiation-induced DNA damage.
The level of 8-OH-dAdo was similar (~0.7 molecules/106
DNA nucleosides) in genomic DNA of non-irradiated cells regardless of
genotype. No change in the 8-OH-dAdo level was observed in
-irradiated wild type cells, indicating complete and rapid repair of
this lesion. The time of complete repair within 30 min is in agreement
with the recently reported repair kinetics of 8-OH-Ade in human cells
(18). In contrast, significantly greater levels of 8-OH-dAdo were
observed in
-irradiated CS-B-null and motif VI mutant cells. In
motif VI mutants, exposure to
-radiation at 5 Gy followed by a
30-min incubation resulted in a higher level of 8-OH-dAdo than exposure
to
-radiation at 2 Gy. These results demonstrate that 8-OH-dAdo
accumulates in a dose-dependent manner in irradiated mutant
cells but does not accumulate in irradiated wild type cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
Previous studies have shown that mutations in CSB cause
a deficiency in cellular repair of 8-OH-Gua (22). The present study shows that CS-B-null and motif VI mutant cells are also deficient in
incision of 8-OH-Ade. Consistent with this observation, 8-OH-Ade accumulates more in genomic DNA of CS-B-null and motif VI mutant cells
than in wild type cells following exposure of cells to
-radiation at
low doses. These results suggest that CS-B-null and motif VI mutant
cells are deficient in cellular repair of 8-OH-Ade. This in turn
indicates that CSB plays an important role in cellular repair of
8-OH-Ade and that the putative helicase motif VI of CSB is
important for this DNA repair function.
CSB is highly homologous to proteins of the SWI/SNF2 family (2, 3, 31). SWI/SNF proteins participate in a wide variety of cellular functions including DNA repair, regulation of transcription, maintenance of chromosome stability, and chromatin remodeling (5, 31-33). SWI/SNF2 proteins contain seven highly conserved motifs for DNA or RNA helicase activity (2, 32), but so far, none has been shown to have this function. Previous experiments were carried out to characterize the cellular response of various CS-B mutant cell lines to different challenges (Table II) (22, 24, 34). We have also mapped the CSB putative helicase motifs and determined their role in cellular repair of 8-OH-Gua (Table II). Those experiments showed that motifs V and VI are essential for the cellular response to oxidative stress and for cellular repair of 8-OH-Gua in genomic DNA. The results presented here show that CSB motif VI also plays an important role in cellular repair of 8-OH-Ade.
|
It is not clear what mechanism underlies the role of CSB in the repair
of 8-OH-Gua and 8-OH-Ade. The enzymes involved specifically in repair
of 8-OH-Ade have not yet been identified (reviewed in Ref. 19), but
some evidence suggests that repair of 8-OH-Ade is mechanistically
different from repair of 8-OH-Gua. Among the bacterial and mammalian
DNA glycosylases, which were investigated for their activity on lesions
in oxidatively damaged DNA, only Escherichia coli
formamidopyrimidine glycosylase (Fpg) exhibited a low activity on
8-OH-Ade in DNA containing multiple modified bases (35, 36). However,
this activity was insignificant when compared with the activity of Fpg
on 8-OH-Gua, 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua), and 4,6-diamino-5-formamidopyrimidine (FapyAde), which are
the principal substrates of Fpg. The inactivity of Fpg was suggested to
result from the absence of a C6-keto group in 8-OH-Ade (37). A recent
study on the cellular repair of modified DNA bases showed that 8-OH-Ade
is efficiently repaired in human cells with kinetics similar to the
repair kinetics of pyrimidine-derived lesions rather than to that of
purine-derived lesions (18). This suggests that human cells possess
enzyme(s) to repair 8-OH-Ade. However, it is not known whether this
repair activity involves BER or NER, or both. A yeast functional
homolog of E. coli Fpg encoded by the OGG1 gene
of Saccharomyces cerevisiae (yOgg1) was shown to excise
8-OH-Gua and FapyGua, but not FapyAde or 8-OH-Ade (38, 39). Human
homologues of yOgg1 were recently isolated (reviewed in Ref. 40). Two
polymorphic forms of hOgg1 namely
-hOgg1-Ser326 and
-hOgg1-Cys326 are produced in human cells. Similar to
yOgg1, both enzymes were reported to efficiently excise 8-OH-Gua and
FapyGua, but not FapyAde or 8-OH-Ade from DNA with multiple lesions
(41). Two enzymes from Drosophila melanogaster also
exhibited similar activities that efficiently excised 8-OH-Gua and
FapyGua from DNA, but not FapyAde and 8-OH-Ade (42, 43). In the same
context, it should be pointed out, that although 8-OH-Ade was repaired
in human cells with kinetics similar to repair kinetics of
pyrimidine-derived lesions, none of the known pyrimidine
lesion-specific DNA glycosylases removed 8-OH-Ade from DNA either
(reviewed in Ref. 19). These studies clearly show that there is a
paucity of knowledge about enzymes that repair 8-OH-Ade in cells or
in vitro. On the other hand, our results confirm results
from the previous study on the cellular repair of 8-OH-Ade in terms of
the ability of human cells to repair this lesion and in terms of its
repair kinetics (18). By studying the biochemical contribution and
expression regulation of CSB to cellular repair of 8-OH-Gua,
we found that CSB itself participates in the catalytic process of
8-OH-Gua incision in vitro, and CSB facilitates
the expression of hOgg1.2
Further research is necessary to understand the mechanism by which CSB
facilitates cellular repair of 8-OH-Ade and to identify other proteins
that might contribute directly or indirectly to cellular repair of this lesion.
8-OH-Ade was identified as its nucleoside form 8-OH-dAdo, and its level and accumulation in genomic DNA of CS-B mutant cells was quantified by means of a recently developed methodology using LC/IDMS (44). The present study is the first application of this technique to the measurement of the formation and repair of 8-OH-dAdo in living cells. The specificity and sensitivity of LC/IDMS in the SIM mode permitted us to detect and quantify 8-OH-dAdo at a level of ~7 molecules/107 DNA nucleosides. Such a level of detection by LC/IDMS-SIM had previously been reported (44). For quantification, we isolated a stable isotope-labeled analog of 8-OH-dAdo in pure form for the first time and used it as the internal standard. It should be pointed out that the use of liquid chromatography/tandem mass spectrometry (LC/MS/MS) has also been reported for the identification of 8-OH-dAdo (45-48). However, the isotope-dilution technique has been applied for quantification in two instances only (45, 48). The sensitivity level for 8-OH-dAdo of this technique in the multiple reaction-monitoring (MRM) mode is similar to that of LC/IDMS-SIM (17). On the other hand, the application of LC/MS/MS-MRM to the measurement of 8-OH-dAdo in living cells has not been reported.
In conclusion, the present study suggests that CSB plays a role in the
cellular repair of 8-OH-Ade and that the putative helicase motif VI of
CSB may be important in this process. In addition, 8-OH-Ade and other
lesions such as 8-OH-Gua might accumulate in the DNA of CS patients and
could potentially contribute to pathology associated with CS.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. C. Chen for DNA extraction.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 410-558-8223; Fax: 410-558-8157; E-mail: vbohr@nih.gov.
Published, JBC Papers in Press, June 11, 2002, DOI 10.1074/jbc.M204814200
2 J. Tuo, C. Chen, X. Zeng, M. Christiansen, and V. A. Bohr, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: CS, Cockayne syndrome; CS-B, Cockayne syndrome group B; BER, base-excision repair; NER, nucleotide-excision repair; TCR, transcription-coupled repair; 8-OH-Ade, 8-hydroxyadenine; 8-OH-dAdo, 8-hydroxy-2'-deoxyadenosine; 8-OH-Gua, 8-hydroxyguanine; 8-OH-dGuo, 8-hydroxy-2'-deoxyguanosine; WCE, whole cell extract; LC/MS, liquid chromatography/mass spectrometry; IDMS, isotope-dilution MS; SIM, selected-ion monitoring; hOGG1, 8-OH-Gua glycosylase/apurinic lyase; 4-NQO, 4-nitroquinoline-1-oxide; Gy, Gray.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Friedberg, E. C. (1996) Bioessays 18, 731-738[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Troelstra, C.,
Odijk, H.,
de Wit, J.,
Westerveld, A.,
Thompson, L. H.,
Bootsma, D.,
and Hoeijmakers, J. H.
(1990)
Mol. Cell. Biol.
10,
5806-5813 |
| 3. | Troelstra, C., van Gool, A., de Wit, J., Vermeulen, W., Bootsma, D., and Hoeijmakers, J. H. (1992) Cell 71, 939-953[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Venema, J.,
Mullenders, L. H.,
Natarajan, A. T.,
van Zeeland, A. A.,
and Mayne, L. V.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
4707-4711 |
| 5. | Balajee, A. S., and Bohr, V. A. (2000) Gene (Amst.) 250, 15-30[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
van Hoffen, A.,
Natarajan, A. T.,
Mayne, L. V.,
van Zeeland, A. A.,
Mullenders, L. H.,
and Venema, J.
(1993)
Nucleic Acids Res.
21,
5890-5895 |
| 7. | Halliwell, B., and Gutteridge, J. M. (1990) Methods Enzymol. 186, 1-85[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Dizdaroglu, M. (1998) Free Radic. Res. 29, 551-563[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Le Page, F.,
Margot, A.,
Grollman, A. P.,
Sarasin, A.,
and Gentil, A.
(1995)
Carcinogenesis
16,
2779-2784 |
| 10. | Shibutani, S., Takeshita, M., and Grollman, A. P. (1991) Nature 349, 431-434[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Guschlbauer, W.,
Duplaa, A. M.,
Guy, A.,
Teoule, R.,
and Fazakerley, G. V.
(1991)
Nucleic Acids Res.
19,
1753-1758 |
| 12. |
Kamiya, H.,
Miura, H.,
Murata-Kamiya, N.,
Ishikawa, H.,
Sakaguchi, T.,
Inoue, H.,
Sasaki, T.,
Masutani, C.,
Hanaoka, F.,
and Nishimura, S.
(1995)
Nucleic Acids Res.
23,
2893-2899 |
| 13. | Shibutani, S., Bodepudi, V., Johnson, F., and Grollman, A. P. (1993) Biochemistry 32, 4615-4621[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Tan, X.,
Grollman, A. P.,
and Shibutani, S.
(1999)
Carcinogenesis
20,
2287-2292 |
| 15. | Wang, D., Kreutzer, D. A., and Essigmann, J. M. (1998) Mutat. Res. 400, 99-115[Medline] [Order article via Infotrieve] |
| 16. |
Wood, M. L.,
Esteve, A.,
Morningstar, M. L.,
Kuziemko, G. M.,
and Essigmann, J. M.
(1992)
Nucleic Acids Res.
20,
6023-6032 |
| 17. | Jaruga, P., Rodriguez, H., and Dizdaroglu, M. (2001) Free Radic. Biol. Med. 31, 336-344[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Jaruga, P.,
and Dizdaroglu, M.
(1996)
Nucleic Acids Res.
24,
1389-1394 |
| 19. | Dizdaroglu, M. (2001) in Free Radicals in Chemistry, Biology and Medicine (Yoshikawa, T. , Toyokuni, S. , Yamamoto, Y. , and Naito, Y., eds) , pp. 58-76, OICA International, London |
| 20. |
Kipling, D.,
and Faragher, R. G.
(1997)
Mol. Pathol.
50,
234-241 |
| 21. |
Dianov, G.,
Bischoff, C.,
Sunesen, M.,
and Bohr, V. A.
(1999)
Nucleic Acids Res.
27,
1365-1368 |
| 22. |
Tuo, J.,
Muftuoglu, M.,
Chen, C.,
Jaruga, P.,
Selzer, R. R.,
Brosh, R. M., Jr.,
Rodriguez, H.,
Dizdaroglu, M.,
and Bohr, V. A.
(2001)
J. Biol. Chem.
276,
45772-45779 |
| 23. | Mayne, L. V., Priestley, A., James, M. R., and Burke, J. F. (1986) Exp. Cell Res. 162, 530-538[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Muftuoglu, M., Selzer1 R, Tuo, J., Brosh, R. M., and Bohr, V. A. (2002) Gene (Amst.) 283, 27-40[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Girard, P. M.,
D'Ham, C.,
Cadet, J.,
and Boiteux, S.
(1998)
Carcinogenesis
19,
1299-1305 |
| 26. |
Zharkov, D. O.,
Rosenquist, T. A.,
Gerchman, S. E.,
and Grollman, A. P.
(2000)
J. Biol. Chem.
275,
28607-28617 |
| 27. | Manley, J. L., Fire, A., Samuels, M., and Sharp, P. A. (1983) Methods Enzymol. 101, 568-582[Medline] [Order article via Infotrieve] |
| 28. | Breen, A. P., and Murphy, J. A. (1995) Free Radic. Biol. Med. 18, 1033-1077[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Dizdaroglu, M. (1992) Mutat. Res. 275, 331-342[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Cavalieri, L. F., and Bendich, A. (1950) J. Am. Chem. Soc. 72, 2587-2594[CrossRef] |
| 31. |
Gorbalenya, A. E.,
Koonin, E. V.,
Donchenko, A. P.,
and Blinov, V. M.
(1989)
Nucleic Acids Res.
17,
4713-4730 |
| 32. |
Eisen, J. A.,
Sweder, K. S.,
and Hanawalt, P. C.
(1995)
Nucleic Acids Res.
23,
2715-2723 |
| 33. | Pazin, M. J., and Kadonaga, J. T. (1997) Cell 88, 737-740[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Selzer, R. R.,
Nyaga, S.,
Tuo, J.,
May, A.,
Muftuoglu, M.,
Christiansen, M.,
Citterio, E.,
Brosh, R. M., Jr.,
and Bohr, V. A.
(2002)
Nucleic Acids Res.
30,
782-793 |
| 35. | Boiteux, S., Gajewski, E., Laval, J., and Dizdaroglu, M. (1992) Biochemistry 31, 106-110[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Karakaya, A.,
Jaruga, P.,
Bohr, V. A.,
Grollman, A. P.,
and Dizdaroglu, M.
(1997)
Nucleic Acids Res.
25,
474-479 |
| 37. |
Tchou, J.,
Bodepudi, V.,
Shibutani, S.,
Antoshechkin, I.,
Miller, J.,
Grollman, A. P.,
and Johnson, F.
(1994)
J. Biol. Chem.
269,
15318-15324 |
| 38. |
Karahalil, B.,
Girard, P. M.,
Boiteux, S.,
and Dizdaroglu, M.
(1998)
Nucleic Acids Res.
26,
1228-1233 |
| 39. |
van der Kemp, P. A.,
Thomas, D.,
Barbey, R., De,
Oliveira, R.,
and Boiteux, S.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5197-5202 |
| 40. | Boiteux, S., and Radicella, J. P. (1999) Biochimie (Paris) 81, 59-67[Medline] [Order article via Infotrieve] |
| 41. |
Dherin, C.,
Radicella, J. P.,
Dizdaroglu, M.,
and Boiteux, S.
(1999)
Nucleic Acids Res.
27,
4001-4007 |
| 42. |
Deutsch, W. A.,
Yacoub, A.,
Jaruga, P.,
Zastawny, T. H.,
and Dizdaroglu, M.
(1997)
J. Biol. Chem.
272,
32857-32860 |
| 43. |
Dherin, C.,
Dizdaroglu, M.,
Doerflinger, H.,
Boiteux, S.,
and Radicella, J. P.
(2000)
Nucleic Acids Res.
28,
4583-4592 |
| 44. |
Jaiswal, M.,
LaRusso, N. F.,
Nishioka, N.,
Nakabeppu, Y.,
and Gores, G. J.
(2001)
Cancer Res.
61,
6388-6393 |
| 45. | Frelon, S., Douki, T., Ravanat, J. L., Pouget, J. P., Tornabene, C., and Cadet, J. (2000) Chem Res. Toxicol. 13, 1002-1010[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Hua, Y., Wainhaus, S. B., Yang, Y., Shen, L., Xiong, Y., Xu, X., Zhang, F., Bolton, J. L., and van Breemen, R. B. (2001) J Am. Soc. Mass Spectrom. 12, 80-87[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Podmore, I. D., Cooper, D., Evans, M. D., Wood, M., and Lunec, J. (2000) Biochem. Biophys. Res. Commun. 277, 764-770[CrossRef][Medline] [Order article via Infotrieve] |
| 48. | Weimann, A., Belling, D., and Poulsen, H. E. (2001) Free Radic. Biol. Med. 30, 757-764[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
H. Menoni, D. Gasparutto, A. Hamiche, J. Cadet, S. Dimitrov, P. Bouvet, and D. Angelov ATP-Dependent Chromatin Remodeling Is Required for Base Excision Repair in Conventional but Not in Variant H2A.Bbd Nucleosomes Mol. Cell. Biol., September 1, 2007; 27(17): 5949 - 5956. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Imam, F. E. Indig, W.-H. Cheng, S. P. Saxena, T. Stevnsner, D. Kufe, and V. A. Bohr Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase Nucleic Acids Res., August 1, 2007; 35(15): 4941 - 4951. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Newman, A. D. Bailey, and A. M. Weiner Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling PNAS, June 20, 2006; 103(25): 9613 - 9618. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muftuoglu, S. Sharma, T. Thorslund, T. Stevnsner, M. M. Soerensen, R. M. Brosh Jr, and V. A. Bohr Cockayne syndrome group B protein has novel strand annealing and exchange activities Nucleic Acids Res., January 12, 2006; 34(1): 295 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horibata, Y. Iwamoto, I. Kuraoka, N. G. J. Jaspers, A. Kurimasa, M. Oshimura, M. Ichihashi, and K. Tanaka From The Cover: Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome PNAS, October 26, 2004; 101(43): 15410 - 15415. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Trzeciak, S. G. Nyaga, P. Jaruga, A. Lohani, M. Dizdaroglu, and M. K. Evans Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145 Carcinogenesis, August 1, 2004; 25(8): 1359 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Peterson and J. Cote Cellular machineries for chromosomal DNA repair Genes & Dev., March 15, 2004; 18(6): 602 - 616. [Full Text] [PDF] |
||||
![]() |
M. S. COOKE, M. D. EVANS, M. DIZDAROGLU, and J. LUNEC Oxidative DNA damage: mechanisms, mutation, and disease FASEB J, July 1, 2003; 17(10): 1195 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jensen, G. Calvayrac, B. Karahalil, V. A. Bohr, and T. Stevnsner Mammalian 8-Oxoguanine DNA Glycosylase 1 Incises 8-Oxoadenine Opposite Cytosine in Nuclei and Mitochondria, while a Different Glycosylase Incises 8-Oxoadenine Opposite Guanine in Nuclei J. Biol. Chem., May 23, 2003; 278(21): 19541 - 19548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. TUO, P. JARUGA, H. RODRIGUEZ, V. A. BOHR, and M. DIZDAROGLU Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress FASEB J, April 1, 2003; 17(6): 668 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christiansen, T. Stevnsner, C. Modin, P. M. Martensen, R. M. Brosh Jr, and V. A. Bohr Functional consequences of mutations in the conserved SF2 motifs and post-translational phosphorylation of the CSB protein Nucleic Acids Res., February 1, 2003; 31(3): 963 - 973. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||